[27-54-pm1] Clinical Pharmacy 4, Appropriate use of medicines | The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

Advanced Search

Session Details

Poster Presentation(E) Pharmaceutical Health Care and Sciences

[27-54-pm1]Clinical Pharmacy 4, Appropriate use of medicines

Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC

Room 54 (C201, Bldg. 2, Area 2 [2F]) (2)

Discusser: Yasuharu Kashiwagura, Kazuhiro Yamamoto

[27-54-pm1-09]Development of doxorubicin resistance by bardoxolone methyl, an Nrf2 activator, in MCF-7 cells

○Yuichiro Hori¹, Shuhei Fukuno¹, Momoka Yatsuda¹, Ann Maekawa¹, Yuichiro Nakano¹, Katsuhito Nagai¹ (1. Osaka Ohtani Univ.)

[27-54-pm1-10]Regulation of drug-metabolizing enzymes and transporters by an Nrf2 activator in renal and intestinal cell models

○Nagai Katsuhito¹, Yuichiro Hori¹, Shuhei Fukuno¹, Keisuke Ohtani², Takashi Yoshida², Rie Watanabe², Takeshi Miura³, Hiroki Konishi¹ (1. Faculty of Pharmacy, Osaka Ohtani University, 2. Department of Pharmacy, Tondabayashi Hospital, 3. Faculty of Environmental Symbiosis, Mukogawa Women's University)

[27-54-pm1-11]Interactions between selective NK1 receptor antagonists and the ABCG2 transporter

○Aya Ino^1,2, Shou Kikkawa¹, Sena Nankai¹, Kana Hashimoto¹, Yuko Nakayama³, Kohji Takara¹ (1. Facul. Pharm. Sci., Hyogo Med. Univ., 2. Comp. Educ. Res. Cent., Kobe Pharm. Univ., 3. Facul. Pharm. Sci., Himeji Dokkyo Univ.)

[27-54-pm1-12]Interactions between hypoxia-inducible factor prolyl-hydroxylase (HIF-PH) inhibitors and the ABCG2 transporter

Aya Ino^1,2, Shou Kikkawa¹, Sena Nankai¹, Kana Hashimoto¹, ○Kohji Takara¹ (1. Facul. Pharm. Sci., Hyogo Med. Univ., 2. Comp. Educ. Res. Cent., Kobe Pharm. Univ.)

[27-54-pm1-13]An opening-related evaluation of powders, the granule divided powder packing and suggestion of the easy opening method

○Harunori Takeshita¹, Yunoka Sato², Aya Ino², Yasushi Habu², Yukako Hatanaka² (1. Yasuda Women's Univ., 2. Kobe Pharm.Univ.)

[27-54-pm1-14]A retrospective study of medication histories of hypotension in patients concurrently using Brimonidine and antihypertensive drugs

○Tadayoshi Shibata^1,2, Tomoya Sakurada³, Nobunori Satoh¹, Shingo Yamazaki¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Momotaro Pharmacy, Togen Ltd., 3. Pharm. Sci., Josai International)

[27-54-pm1-15]Evaluation of drug exposure during the use of sampling adapters in the simple suspension method

○Rena Saku^1,2, Kanae Tokita¹, Kota Akiyama¹, Yuriko Namiki¹, Noriaki Hidaka³, Yu Sasaki³, Sakae Saito², Manabu Amano⁴, Kenshi Takechi^5,6, Shingo Takatori^5,6, Mamoru Tanaka³, Manahito Aoki^1,2, Mitsuhiro Sugawara^1,2 (1. Sch.Pharm.,Kitasato Univ., 2. Div. Pharm., Kitasato Univ. Med. Cent., 3. Div.Pharm.,Ehime Univ.Hosp., 4. Kagawa Sch. Pharm., Tokushima Bunri Univ., 5. Sch.Pharm.,Matsuyama Univ., 6. Grad. Sch. Pharm. Sci., Matsuyama Univ.)

[27-54-pm1-16]Effects of community pharmacist interventions on polypharmacy prescriptions : insights from the polypharmacy project.

○Hiroshi Takahashi^1,5, Keita Shoji¹, Tomoya Aiso², Hidemi Suzuki², Yukie Hoshiko², Kenshi Nishimura², Manabu Arai², Takashi Hatae³, Mitsuru Sasaki⁴, Akitomo Kumagai⁵ (1. Division of Community Healthcare and Pharm. Sci.,Iwate Medical Univ., 2. JMDC Inc., 3. Hiroshima Bunka Gakuen Univ., 4. Iwate Pref. Health Care Union., 5. Iwate Pharmaceutical Association.)

Back to Category List